# SAR1B

## Overview
The SAR1B gene encodes the secretion associated Ras related GTPase 1B, a small GTPase that plays a critical role in the intracellular transport system, specifically in the formation and function of coat protein complex II (COPII) vesicles. These vesicles are essential for the transport of proteins from the endoplasmic reticulum to the Golgi apparatus, a key step in the secretory pathway. The SAR1B protein acts as a molecular switch, cycling between active and inactive states, which is vital for its function in vesicle formation and cargo selection. Predominantly expressed in the intestine and liver, SAR1B is crucial for the secretion of large lipoproteins, such as chylomicrons and very low-density lipoproteins (VLDL), and plays a significant role in lipid metabolism and cholesterol homeostasis (Levy2024Unraveling; Saito2017Regulation). Mutations in the SAR1B gene are linked to chylomicron retention disease, highlighting its clinical significance in lipid absorption and metabolic disorders (Georges2011Molecular). Additionally, SAR1B has been implicated in colorectal cancer, where its expression levels may influence tumor progression and patient prognosis (Lu2020Knockdown).

## Function
The SAR1B gene encodes a small GTPase that is integral to the formation and function of coat protein complex II (COPII) vesicles, which are essential for transporting proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. In healthy human cells, SAR1B acts as a molecular switch, alternating between an active GTP-bound state and an inactive GDP-bound state, which is crucial for the proper functioning of the secretory pathway (Georges2011Molecular; Levy2024Unraveling). SAR1B is predominantly expressed in the intestine and liver, where it facilitates the secretion of large lipoproteins such as chylomicrons and very low-density lipoproteins (VLDL) (Saito2017Regulation).

SAR1B's role extends to influencing membrane curvature and vesicle size, which is vital for the transport of large cargoes like chylomicrons. This function is distinct from its paralogue SAR1A, which is involved in the transport of smaller proteins (Georges2011Molecular). SAR1B is also involved in lipid metabolism, impacting cholesterol homeostasis and the secretion of high-density lipoprotein (HDL) and apolipoprotein A-I (Apo A-I) in the small intestine (Levy2024Unraveling). These processes are critical for maintaining cellular homeostasis and proper metabolic function.

## Clinical Significance
Mutations in the SAR1B gene are primarily associated with chylomicron retention disease (CMRD), also known as Anderson's disease. This rare autosomal recessive disorder is characterized by lipid malabsorption, hypobetalipoproteinemia, and the absence of apoB48 in the postprandial state. Mutations in SAR1B lead to defects in chylomicron secretion, resulting in clinical manifestations such as malabsorption syndrome, steatorrhea, and failure to thrive. Neurological symptoms may also develop in untreated individuals, including loss of deep tendon reflexes, areflexia, ataxia, and myopathy (Georges2011Molecular).

Specific mutations identified in SAR1B include homozygous deletions and frameshift mutations, which result in truncated and likely non-functional proteins. These mutations disrupt the gene's interaction with the endoplasmic reticulum and COPII machinery, leading to chylomicron secretion failure (Georges2011Molecular; Auclair2021Sar1b). 

Alterations in SAR1B expression have also been implicated in colorectal cancer (CRC). SAR1B is overexpressed in CRC tissues, and its knockdown in cancer cell lines suppresses proliferation and induces apoptosis, suggesting a potential tumorigenic role. High SAR1B expression is associated with shorter overall survival in CRC patients, indicating its potential as a prognostic marker (Lu2020Knockdown).

## Interactions
SAR1B, a small GTPase, is involved in the formation of COPII-coated vesicles, which are essential for transporting proteins from the endoplasmic reticulum to the Golgi apparatus. SAR1B interacts with several key proteins in the COPII complex, including SEC23, SEC24, and SEC31. These interactions facilitate the assembly of the COPII coat and the selection of cargo for vesicle transport. SAR1B, upon activation by GTP binding, recruits SEC23 and SEC24 to form a pre-budding complex with cargo proteins. The outer-coat complex, composed of SEC13 and SEC31, then binds to SEC23/SEC24, enhancing the GTPase-activating protein (GAP) activity of SEC23 towards SAR1B, which is crucial for completing the coat assembly (Saito2017Regulation).

In colorectal cancer (CRC) cells, SAR1B is part of a protein-protein interaction network that includes proteins such as HOOK1, HOOK3, and RAB9A, which are downregulated following SAR1B knockdown. Conversely, proteins like Akt, ARRDC3, and Ephb are upregulated. These interactions suggest that SAR1B is involved in various signaling pathways that may contribute to CRC progression (Lu2020Knockdown). SAR1B's role in these interactions highlights its importance in both normal cellular transport processes and pathological conditions.


## References


[1. (Georges2011Molecular) Amandine Georges, Jessica Bonneau, Dominique Bonnefont-Rousselot, Jacqueline Champigneulle, Jean P Rabès, Marianne Abifadel, Thomas Aparicio, Jean C Guenedet, Eric Bruckert, Catherine Boileau, Alain Morali, Mathilde Varret, Lawrence P Aggerbeck, and Marie E Samson-Bouma. Molecular analysis and intestinal expression of sar1 genes and proteins in anderson’s disease (chylomicron retention disease). Orphanet Journal of Rare Diseases, January 2011. URL: http://dx.doi.org/10.1186/1750-1172-6-1, doi:10.1186/1750-1172-6-1. This article has 72 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1750-1172-6-1)

[2. (Levy2024Unraveling) Emile Levy, Catherine Fallet-Bianco, Nickolas Auclair, Natalie Patey, Valérie Marcil, Alain Théophile Sané, and Schohraya Spahis. Unraveling chylomicron retention disease enhances insight into sar1b gtpase functions and mechanisms of actions, while shedding light of intracellular chylomicron trafficking. Biomedicines, 12(7):1548, July 2024. URL: http://dx.doi.org/10.3390/biomedicines12071548, doi:10.3390/biomedicines12071548. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biomedicines12071548)

[3. (Saito2017Regulation) Kota Saito, Miharu Maeda, and Toshiaki Katada. Regulation of the sar1 gtpase cycle is necessary for large cargo secretion from the endoplasmic reticulum. Frontiers in Cell and Developmental Biology, August 2017. URL: http://dx.doi.org/10.3389/fcell.2017.00075, doi:10.3389/fcell.2017.00075. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2017.00075)

[4. (Auclair2021Sar1b) Nickolas Auclair, Alain T. Sané, Lena Ahmarani, Nathalie Patey, Jean-François Beaulieu, Noel Peretti, Schohraya Spahis, and Emile Levy. Sar1b mutant mice recapitulate gastrointestinal abnormalities associated with chylomicron retention disease. Journal of Lipid Research, 62:100085, 2021. URL: http://dx.doi.org/10.1016/j.jlr.2021.100085, doi:10.1016/j.jlr.2021.100085. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jlr.2021.100085)

[5. (Lu2020Knockdown) Yong Lu, Shen-Kang Zhou, Rui Chen, Liang-Xian Jiang, Lei-Lei Yang, and Tie-Nan Bi. Knockdown of sar1b suppresses proliferation and induces apoptosis of rko colorectal cancer cells. Oncology Letters, 20(5):1–1, September 2020. URL: http://dx.doi.org/10.3892/ol.2020.12048, doi:10.3892/ol.2020.12048. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2020.12048)